<p>Fresenius Medical Care AG  Co. KGaA（纽约证券交易所代码：FMS - 获取免费报告）的股票在目前覆盖该公司的九位分析师中被评定为 “减持”，Marketbeat.com 报道。四位投资分析师对该股票给予了卖出建议，五位则对该公司给予了持有建议。在过去一年中，发布报告的券商对该股票的平均十二个月目标价为 28.00 美元。</p>
<ul>
<li>医院股票 - 最值得购买的医院股票</li>
</ul>
<p>最近，一些分析师对该股票发表了评论。华尔街禅在 5 月 9 日的研究报告中将 Fresenius Medical Care AG  Co. KGaA 的股票评级从 “买入” 下调至 “持有”。Erste Group Bank 在 2 月 5 日的研究报告中将 Fresenius Medical Care AG  Co. KGaA 的股票评级从 “强力买入” 下调至 “持有”。Weiss Ratings 在 5 月 7 日的研究报告中将 Fresenius Medical Care AG  Co. KGaA 的股票评级从 “持有（c+）” 下调至 “持有（c）”。花旗集团在 4 月 24 日的研究报告中重申了 Fresenius Medical Care AG  Co. KGaA 的 “中性” 评级。最后，杰富瑞金融集团在 5 月 8 日的研究报告中将 Fresenius Medical Care AG  Co. KGaA 的股票评级从 “强烈卖出” 上调至 “适度卖出”。</p>
<p><strong>阅读我们关于 FMS 的最新报告</strong></p>
<h2>Fresenius Medical Care AG  Co. KGaA 的机构交易</h2>
<ul>
<li>最佳医疗股票 - 现在值得购买的医疗股票</li>
</ul>
<p>一些机构投资者和对冲基金最近调整了对该股票的持有。EverSource Wealth Advisors LLC 在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 50.3%。EverSource Wealth Advisors LLC 现在拥有 4,135 股该公司的股票，价值 93,000 美元，此前在上一季度购买了 1,383 股。加拿大皇家银行在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 479.2%。加拿大皇家银行现在拥有 216,861 股该公司的股票，价值 4,893,000 美元，此前在上一季度购买了 179,418 股。Quantinno Capital Management LP 在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 15.7%。Quantinno Capital Management LP 现在拥有 341,343 股该公司的股票，价值 7,701,000 美元，此前在上一季度购买了 46,428 股。Sei Investments Co.在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 80.7%。Sei Investments Co.现在拥有 120,704 股该公司的股票，价值 2,723,000 美元，此前在上一季度购买了 53,922 股。最后，Cetera Investment Advisers 在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 76.7%。Cetera Investment Advisers 现在拥有 15,917 股该公司的股票，价值 359,000 美元，此前在上一季度购买了 6,909 股。对冲基金和其他机构投资者持有该公司 8.37% 的股份。</p>
<h2>Fresenius Medical Care AG  Co. KGaA 股价上涨 1.4%</h2>
<p>Fresenius Medical Care AG  Co. KGaA 的股票在周五开盘价为 22.51 美元。该公司的 50 日简单移动平均线为 22.44 美元，200 日简单移动平均线为 23.08 美元。该公司的市值为 125.7 亿美元，市盈率为 11.85，市盈率增长比率为 4.01，贝塔值为 0.81。Fresenius Medical Care AG  Co. KGaA 的 52 周低点为 20.02 美元，52 周高点为 29.71 美元。该公司的债务与股本比率为 0.40，速动比率为 0.86，流动比率为 1.20。</p>
<p>Fresenius Medical Care AG  Co. KGaA（纽约证券交易所代码：FMS - 获取免费报告）最近在 3 月 31 日发布了季度财报。该公司报告本季度每股收益为 1.05 美元。该季度的营业收入为 53.4 亿美元。Fresenius Medical Care AG  Co. KGaA 的净利润率为 4.88%，股本回报率为 8.90%。作为一个整体，股票分析师预测 Fresenius Medical Care AG  Co. KGaA 在当前财政年度将发布 2.24 美元的每股收益。</p>
<h2>Fresenius Medical Care AG  Co. KGaA 增加股息</h2>
<p>该公司最近还宣布了一项年度股息，将于 6 月 8 日支付。5 月 22 日的股东将获得每股 0.8716 美元的股息。这比 Fresenius Medical Care AG  Co. KGaA 之前的年度股息 0.79 美元有所增加。这代表了 387.0% 的股息收益率。该股息的除息日期为 5 月 22 日。Fresenius Medical Care AG  Co. KGaA 目前的股息支付比率为 30.00%。</p>
<h2>Fresenius Medical Care AG  Co. KGaA 公司简介</h2>
<p>（获取免费报告）</p>
<p>Fresenius Medical Care AG  Co KGaA 是全球最大的肾脏疾病产品和服务的综合供应商。该公司的主要业务活动包括运营透析诊所以及制造和分销透析设备、透析机、透析器、耗材和相关疗法。通过其全球诊所网络，Fresenius Medical Care 提供全面的肾脏护理，包括血液透析和腹膜透析治疗、患者教育和支持服务。</p>
<p>在其产品部门，该公司设计和生产透析机、水处理系统以及高通量透析器和血管通路等一次性产品。</p>
<h2>另请参阅</h2>
<ul>
<li>我们更看好的五只股票，超过 Fresenius Medical Care AG  Co. KGaA</li>
<li>Meta Platforms 裁员 10% 引发关于人工智能支出的更大问题</li>
<li>随着小型股表现持续，这两只 ETF 提供了投资机会</li>
<li>硅谷动荡：人工智能交易超越 NVIDIA</li>
<li>上周 Hims  Hers 财报失利的银 lining</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UWU3ltYm9sPUZNUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UWU3ltYm9sPUZNUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Fresenius Medical Care AG &amp; Co. KGaA 吗？</h2>
<p>在考虑 Fresenius Medical Care AG &amp; Co. KGaA 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Fresenius Medical Care AG &amp; Co. KGaA 并不在名单上。</p>
<p>尽管 Fresenius Medical Care AG &amp; Co. KGaA 目前在分析师中被评为减持评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Fresenius Medical Care AG & Co. KGaA（纽约证券交易所代码：FMS）获得了九位分析师的共识评级为 “减持”，其中四位建议卖出，五位建议持有。平均目标价为 28.00 美元。最近的评级变动包括来自 Wall Street Zen 和 Erste Group Bank 的下调。该股票开盘价为 22.51 美元，市值为 125.7 亿美元。公司报告了上一季度每股收益为 1.05 美元，并宣布年度股息为 0.8716 美元</p>

<p>Shares of Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - Get Free Report) have been assigned an average rating of &#34;Reduce&#34; from the nine analysts that are currently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a sell recommendation and five have issued a hold recommendation on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $28.00.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG  Co. KGaA（纽约证券交易所代码：FMS - 获取免费报告）的股票在目前覆盖该公司的九位分析师中被评定为 “减持”，Marketbeat.com 报道。四位投资分析师对该股票给予了卖出建议，五位则对该公司给予了持有建议。在过去一年中，发布报告的券商对该股票的平均十二个月目标价为 28.00 美元。</p>
</div><ul>
<li>Hospital Stocks - Best Hospital Stocks to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>医院股票 - 最值得购买的医院股票</li>
</ul>
</div><p>A number of analysts have recently commented on the stock. Wall Street Zen cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, May 9th. Erste Group Bank cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, February 5th. Weiss Ratings cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;hold (c+)&#34; rating to a &#34;hold (c)&#34; rating in a research note on Thursday, May 7th. Citigroup reissued a &#34;neutral&#34; rating on shares of Fresenius Medical Care AG &amp; Co. KGaA in a research note on Friday, April 24th. Finally, Jefferies Financial Group raised shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;strong sell&#34; rating to a &#34;moderate sell&#34; rating in a research note on Friday, May 8th.</p>
<div class="lb-trans"><p>最近，一些分析师对该股票发表了评论。华尔街禅在 5 月 9 日的研究报告中将 Fresenius Medical Care AG  Co. KGaA 的股票评级从 “买入” 下调至 “持有”。Erste Group Bank 在 2 月 5 日的研究报告中将 Fresenius Medical Care AG  Co. KGaA 的股票评级从 “强力买入” 下调至 “持有”。Weiss Ratings 在 5 月 7 日的研究报告中将 Fresenius Medical Care AG  Co. KGaA 的股票评级从 “持有（c+）” 下调至 “持有（c）”。花旗集团在 4 月 24 日的研究报告中重申了 Fresenius Medical Care AG  Co. KGaA 的 “中性” 评级。最后，杰富瑞金融集团在 5 月 8 日的研究报告中将 Fresenius Medical Care AG  Co. KGaA 的股票评级从 “强烈卖出” 上调至 “适度卖出”。</p>
</div><p><strong>Read Our Latest Report on FMS</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 FMS 的最新报告</strong></p>
</div><h2>Institutional Trading of Fresenius Medical Care AG &amp; Co. KGaA</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG  Co. KGaA 的机构交易</h2>
</div><ul>
<li>Best Healthcare Stocks - Healthcare Stocks to Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>最佳医疗股票 - 现在值得购买的医疗股票</li>
</ul>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC increased its stake in shares of Fresenius Medical Care AG &amp; Co. KGaA by 50.3% during the first quarter. EverSource Wealth Advisors LLC now owns 4,135 shares of the company's stock worth $93,000 after purchasing an additional 1,383 shares in the last quarter. Royal Bank of Canada increased its stake in shares of Fresenius Medical Care AG &amp; Co. KGaA by 479.2% during the first quarter. Royal Bank of Canada now owns 216,861 shares of the company's stock worth $4,893,000 after purchasing an additional 179,418 shares in the last quarter. Quantinno Capital Management LP increased its stake in shares of Fresenius Medical Care AG &amp; Co. KGaA by 15.7% during the first quarter. Quantinno Capital Management LP now owns 341,343 shares of the company's stock worth $7,701,000 after purchasing an additional 46,428 shares in the last quarter. Sei Investments Co. increased its stake in shares of Fresenius Medical Care AG &amp; Co. KGaA by 80.7% during the first quarter. Sei Investments Co. now owns 120,704 shares of the company's stock worth $2,723,000 after purchasing an additional 53,922 shares in the last quarter. Finally, Cetera Investment Advisers grew its stake in Fresenius Medical Care AG &amp; Co. KGaA by 76.7% during the 1st quarter. Cetera Investment Advisers now owns 15,917 shares of the company's stock valued at $359,000 after acquiring an additional 6,909 shares in the last quarter. Hedge funds and other institutional investors own 8.37% of the company's stock.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近调整了对该股票的持有。EverSource Wealth Advisors LLC 在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 50.3%。EverSource Wealth Advisors LLC 现在拥有 4,135 股该公司的股票，价值 93,000 美元，此前在上一季度购买了 1,383 股。加拿大皇家银行在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 479.2%。加拿大皇家银行现在拥有 216,861 股该公司的股票，价值 4,893,000 美元，此前在上一季度购买了 179,418 股。Quantinno Capital Management LP 在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 15.7%。Quantinno Capital Management LP 现在拥有 341,343 股该公司的股票，价值 7,701,000 美元，此前在上一季度购买了 46,428 股。Sei Investments Co.在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 80.7%。Sei Investments Co.现在拥有 120,704 股该公司的股票，价值 2,723,000 美元，此前在上一季度购买了 53,922 股。最后，Cetera Investment Advisers 在第一季度将其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 76.7%。Cetera Investment Advisers 现在拥有 15,917 股该公司的股票，价值 359,000 美元，此前在上一季度购买了 6,909 股。对冲基金和其他机构投资者持有该公司 8.37% 的股份。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Trading Up 1.4%</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG  Co. KGaA 股价上涨 1.4%</h2>
</div><p>Shares of Fresenius Medical Care AG &amp; Co. KGaA stock opened at $22.51 on Friday. The firm has a 50-day simple moving average of $22.44 and a two-hundred day simple moving average of $23.08. The company has a market cap of $12.57 billion, a P/E ratio of 11.85, a price-to-earnings-growth ratio of 4.01 and a beta of 0.81. Fresenius Medical Care AG &amp; Co. KGaA has a fifty-two week low of $20.02 and a fifty-two week high of $29.71. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.86 and a current ratio of 1.20.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG  Co. KGaA 的股票在周五开盘价为 22.51 美元。该公司的 50 日简单移动平均线为 22.44 美元，200 日简单移动平均线为 23.08 美元。该公司的市值为 125.7 亿美元，市盈率为 11.85，市盈率增长比率为 4.01，贝塔值为 0.81。Fresenius Medical Care AG  Co. KGaA 的 52 周低点为 20.02 美元，52 周高点为 29.71 美元。该公司的债务与股本比率为 0.40，速动比率为 0.86，流动比率为 1.20。</p>
</div><p>Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - Get Free Report) last issued its quarterly earnings data on Tuesday, March 31st. The company reported $1.05 earnings per share for the quarter. The business had revenue of $5.34 billion during the quarter. Fresenius Medical Care AG &amp; Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. As a group, equities analysts predict that Fresenius Medical Care AG &amp; Co. KGaA will post 2.24 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG  Co. KGaA（纽约证券交易所代码：FMS - 获取免费报告）最近在 3 月 31 日发布了季度财报。该公司报告本季度每股收益为 1.05 美元。该季度的营业收入为 53.4 亿美元。Fresenius Medical Care AG  Co. KGaA 的净利润率为 4.88%，股本回报率为 8.90%。作为一个整体，股票分析师预测 Fresenius Medical Care AG  Co. KGaA 在当前财政年度将发布 2.24 美元的每股收益。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Increases Dividend</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG  Co. KGaA 增加股息</h2>
</div><p>The business also recently announced an annual dividend, which will be paid on Monday, June 8th. Stockholders of record on Friday, May 22nd will be paid a dividend of $0.8716 per share. This is an increase from Fresenius Medical Care AG &amp; Co. KGaA's previous annual dividend of $0.79. This represents a dividend yield of 387.0%. The ex-dividend date of this dividend is Friday, May 22nd. Fresenius Medical Care AG &amp; Co. KGaA's dividend payout ratio is presently 30.00%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项年度股息，将于 6 月 8 日支付。5 月 22 日的股东将获得每股 0.8716 美元的股息。这比 Fresenius Medical Care AG  Co. KGaA 之前的年度股息 0.79 美元有所增加。这代表了 387.0% 的股息收益率。该股息的除息日期为 5 月 22 日。Fresenius Medical Care AG  Co. KGaA 目前的股息支付比率为 30.00%。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Company Profile</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG  Co. KGaA 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Fresenius Medical Care AG &amp; Co KGaA is the world's largest integrated provider of products and services for individuals with renal diseases. The company's primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG  Co KGaA 是全球最大的肾脏疾病产品和服务的综合供应商。该公司的主要业务活动包括运营透析诊所以及制造和分销透析设备、透析机、透析器、耗材和相关疗法。通过其全球诊所网络，Fresenius Medical Care 提供全面的肾脏护理，包括血液透析和腹膜透析治疗、患者教育和支持服务。</p>
</div><p>In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.</p>
<div class="lb-trans"><p>在其产品部门，该公司设计和生产透析机、水处理系统以及高通量透析器和血管通路等一次性产品。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than Fresenius Medical Care AG &amp; Co. KGaA</li>
<li>Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending</li>
<li>As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure</li>
<li>Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA</li>
<li>The Silver Lining of Last Week's Hims &amp; Hers Earnings Miss</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，超过 Fresenius Medical Care AG  Co. KGaA</li>
<li>Meta Platforms 裁员 10% 引发关于人工智能支出的更大问题</li>
<li>随着小型股表现持续，这两只 ETF 提供了投资机会</li>
<li>硅谷动荡：人工智能交易超越 NVIDIA</li>
<li>上周 Hims  Hers 财报失利的银 lining</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZNUw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=FMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Fresenius Medical Care AG &amp; Co. KGaA Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Fresenius Medical Care AG &amp; Co. KGaA 吗？</h2>
</div><p>Before you consider Fresenius Medical Care AG &amp; Co. KGaA, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Fresenius Medical Care AG &amp; Co. KGaA 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care AG &amp; Co. KGaA wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Fresenius Medical Care AG &amp; Co. KGaA 并不在名单上。</p>
</div><p>While Fresenius Medical Care AG &amp; Co. KGaA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Fresenius Medical Care AG &amp; Co. KGaA 目前在分析师中被评为减持评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Given Consensus Rating of "Reduce" by Analysts

Market Beat

Fresenius Medical Care

花旗

Fresenius Medical Care AG & Co. KGaA（NYSE:FMS）被分析师一致给予 “减持” 评级